Defining neurodegeneration on Guam by targeted genomic sequencing

Annals of Neurology

Volumn 77, Issue 3, 2015, Pages 458-468

  Steele, John C ^a   Guella, Ilaria ^b   Szu Tu, Chelsea ^b   Lin, Michelle K ^b   Thompson, Christina ^b   Evans, Daniel M ^b   Sherman, Holly E ^b   Vilariño Güell, Carles ^b   Gwinn, Katrina ^c   Morris, Huw ^d   Dickson, Dennis W ^e   Farrer, Matthew J ^b  

^a Micronesian Health Study II   (Guam)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CAG REPEAT; CHAMORRO (PEOPLE); CONTROLLED STUDY; DCTN1 GENE; DEGENERATIVE DISEASE; DEMENTIA; FEMALE; FUS GENE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; GENOMICS; GUAM; HETEROZYGOSITY; HOMOZYGOSITY; HTT GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PARKINSONISM; PINK1 GENE; POPULATION GENETICS; PRIORITY JOURNAL; GENETICS; MIDDLE AGED; PARKINSON DISEASE; PEDIGREE; SYNDROME; VERY ELDERLY;

DYNACTIN; HTT PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; NERVE PROTEIN; PROTEIN KINASE; PTEN-INDUCED PUTATIVE KINASE; RNA BINDING PROTEIN;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; DEMENTIA; GUAM; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PEDIGREE; PROTEIN KINASES; RNA-BINDING PROTEIN FUS; SYNDROME;

EID: 84923658615     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24346     Document Type: Article

References (42)

1. Steele JC Parkinsonism-dementia complex of Guam. Mov Disord 2005; 20(SUPPL. 12):S99-S107.
2. Kuzuhara S, Kokubo Y, Sasaki R, et al. Familial amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii Peninsula of Japan: clinical and neuropathological study and tau analysis. Ann Neurol 2001; 49: 501-511.
3. Gajdusek DC, Salazar AM. Amyotrophic lateral sclerosis and par-kinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea. Neurology 1982; 32: 107-126.
4. Malamud N, Hirano A, Kurland LT. Pathoanatomic changes in amyotrophic lateral sclerosis on Guam. Special reference to the occurrence of neurofibrillary changes. Arch Neurol 1961; 5: 401-415.
5. Morris HR, Al-Sarraj S, Schwab C, et al. A clinical and pathological study of motor neurone disease on Guam. Brain 2001; 124: 2215-2222.
6. Elizan TS, Hirano A, Abrams BM, et al. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam. Neurological reevaluation. Arch Neurol 1966; 14: 356-368.
7. Hirano A, Malamud N, Kurland LT. Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features. Brain 1961; 84: 662-679.
8. Miklossy J, Steele JC, Yu S, et al. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC). Acta Neuropathol 2008; 116: 625-637.
9. Anderson FH, Richardson EP Jr, Okazaki H, Brody JA. Neurofibrillary degeneration on Guam: frequency in Chamorros and non Chamorros with no known neurological disease. Brain 1979; 102: 65-77.
10. Sundar PD, Yu CE, Sieh W, et al. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia. Hum Mol Genet 2007; 16: 295-306.
11. Dombroski BA, Galasko DR, Mata IF, et al. C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex. JAMA Neurol 2013; 70: 742-745.
12. Galasko D, Salmon D, Gamst A, et al. Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE. Neurology 2007; 68: 1772-1781.
13. Sieh W, Choi Y, Chapman NH, et al. Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates. Hum Mol Genet 2009; 18: 3725-3738.
14. Ahlskog JE, Waring SC, Kurland LT, et al. Guamanian neurodege-nerative disease: investigation of the calcium metabolism/heavy metal hypothesis. Neurology 1995; 45: 1340-1344.
15. Gibbs CJ Jr, Gajdusek DC. Amyotrophic lateral sclerosis, Parkinson's disease, and the amyotrophic lateral sclerosis-parkinsonism-dementia complex on Guam: a review and summary of attempts to demonstrate infection as the aetiology. J Clin Pathol Suppl (R Coll Pathol) 1972; 6: 132-140.
16. Borenstein AR, Mortimer JA, Schofield E, et al. Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam. Neurology 2007; 68: 1764-1771.
17. Cox PA, Sacks OW. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology 2002; 58: 956-959.
18. Steele JC, McGeer PL. The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology 2008; 70: 1984-1990.
19. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
20. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
21. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005; 128: 1247-1258.
22. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38:e164.
23. Karolchik D, Barber GP, Casper J, et al. The UCSC Genome Browser database: 2014 update. Nucleic Acids Res 2014; 42:D764-D770.
24. Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 2010; 20: 110-121.
25. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009; 4: 1073-1081.
26. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-249.
27. Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. Mutation Taster evaluates disease-causing potential of sequence alterations. Nat Methods 2010; 7: 575-576.
28. Rogaeva E, Johnson J, Lang AE, et al. Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol 2004; 61: 1898-1904.
29. Merner ND, Girard SL, Catoire H, et al. Exome sequencing identifies FUS mutations as a cause of essential tremor. Am J Hum Genet 2012; 91: 313-319.
30. Monmaney T. Annals of science: this obscure malady. New Yorker October 29, 1990: 85-113.
31. Plato CC, Galasko D, Garruto RM, et al. ALS and PDC of Guam - forty-year follow-up. Neurology 2002; 58: 765-773.
32. Samaranch L, Lorenzo-Betancor O, Arbelo JM, et al. PINK1-linked parkinsonism is associated with Lewy body pathology. Brain 2010; 133: 1128-1142.
33. Geser F, Winton MJ, Kwong LK, et al. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 2008; 115: 133-145.
34. Klein C, Lohmann-Hedrich K, Rogaeva E, et al. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 2007; 6: 652-662.
35. Puls I, Jonnakuty C, LaMonte BH, et al. Mutant dynactin in motor neuron disease. Nat Genet 2003; 33: 455-456.
36. Farrer MJ, Hulihan MM, Kachergus JM, et al. DCTN1 mutations in Perry syndrome. Nat Genet 2009; 41: 163-165.
37. Araki A, Tsuboi Y, Daechsel J, et al. A novel DCTN1 mutation with late-onset parkinsonism and frontotemporal atrophy. Mov Disord 2014; 29: 1201-1204.
38. Vilarino-Guell C, Rajput A, Milnerwood AJ, et al. DNAJC13 mutations in Parkinson disease. Hum Mol Genet 2014; 23: 1794-1801.
39. Gydesen S, Brown JM, Brun A, et al. Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology 2002; 59: 1585-1594.
40. Skibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005; 37: 806-808.
41. Yu CE, Bird TD, Bekris LM, et al. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol 2010; 67: 161-170.
42. Garruto RM, Yanagihara R, Gajdusek DC. Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonismdementia on Guam. Neurology 1985; 35: 193-198.